Most Popular Products





Bremelanotide (PT-141)
5.4 USD ($)/Piece
Product Details:
- Taste Other
- Purity Not less than 99%
- Storage Freezer
- Properties PT-141 (also known as bremelanotide) is a melanocortin receptor agonist that primarily acts on melanocortin receptor type 4 (MC4R), which is present in the central nervous system (CNS) and regulates functions such as appetite, sexual behavior, and skin pigmentation. Chemical Properties: PT-141 is a cyclic peptide that is highly soluble in water and has a pKa value of 7.3. Its molecular formula is C50H68N14O10 and its molecular weight is 1025.163. PT-141 is a white powder with a melting point of approximately 150 C and a density of 1.4 0.1 g/cm3. Biological Activity: PT-141 is an analog of -melanocyte stimulating hormone ( -MSH) that activates mPOA in the central nervous system and other hypothalamic and limbic areas of the brain involved in sexual behavior. It is primarily used to study Hypoactive Sexual Desire Disorder(HSDD). In addition, PT-141 also has the effect of stimulating the production and secretion of melanin.
- Appearance White powder
- Solubility Slightly soluble in water, DMSO and methanol, requires ultrasound-assisted dissolution.
- Poisonous NO
- Click to View more
X
Bremelanotide (PT-141) Price And Quantity
- 1 Piece
- 5.4 USD ($)/Piece
Bremelanotide (PT-141) Product Specifications
- Other
- Freezer
- Not less than 99%
- White powder
- PT-141 (also known as bremelanotide) is a melanocortin receptor agonist that primarily acts on melanocortin receptor type 4 (MC4R), which is present in the central nervous system (CNS) and regulates functions such as appetite, sexual behavior, and skin pigmentation. Chemical Properties: PT-141 is a cyclic peptide that is highly soluble in water and has a pKa value of 7.3. Its molecular formula is C50H68N14O10 and its molecular weight is 1025.163. PT-141 is a white powder with a melting point of approximately 150 C and a density of 1.4 0.1 g/cm3. Biological Activity: PT-141 is an analog of -melanocyte stimulating hormone ( -MSH) that activates mPOA in the central nervous system and other hypothalamic and limbic areas of the brain involved in sexual behavior. It is primarily used to study Hypoactive Sexual Desire Disorder(HSDD). In addition, PT-141 also has the effect of stimulating the production and secretion of melanin.
- Slightly soluble in water, DMSO and methanol, requires ultrasound-assisted dissolution.
- C50H68N14O10
- NO
- 1) Indications: PT-141 is mainly used to treat female hypoactive sexual desire disorder (HSDD), especially premenopausal women. It was approved by the US FDA on June 21st, 2019, with the trade name Vyleesi , and the dosage form is subcutaneous injection. Efficacy Characteristics: Clinical trials show that its efficacy peaks about 4 hours after injection, can quickly stimulate sexual desire, and is non-addictive.
- Lyophilized Powder
- 1607799-13-2
- Reagent Grade
- Bremelanotide
- Powder
- 1025.16
- 24 Months
- medicine
- Other
Bremelanotide (PT-141) Trade Information
- Shenzhen, Dongguan, Shanghai or Beijing
- Paypal Telegraphic Transfer (T/T) Western Union
- 5000 Piece Per Week
- 3 Days
- Yes
- If order is confirmed we will reimburse the sample cost
- 10 Vials per Box (10mg/vial*10vials).
- Central America North America South America Eastern Europe Western Europe Australia
Product Description
PT-141 (Bremelanotide) is a synthetic peptide drug that acts as an analog of -melanocyte stimulating hormone (-MSH) by activating melanocortin receptors (MCR).
PT-141 is mainly used to study and treat female sexual dysfunction, especially hypoactive sexual desire disorder.
In clinical trials, PT-141 showed significant effects on premenopausal women with hypoactive sexual desire disorder and helped them maintain normal sexual desire.
Tell us about your requirement

Price:
Quantity
Select Unit
- 50
- 100
- 200
- 250
- 500
- 1000+
Additional detail
Mobile number
Email
Other Products in 'Peptide Preparations' category
![]() |
DALIAN HANDOM CHEMICALS CO.,LTD.
All Rights Reserved.(Terms of Use) Developed and Managed by Infocom Network Private Limited. |